Guangzhou Beisheng Pharmaceutical Technology

Guangzhou Beisheng Pharmaceutical Technology is a prominent Chinese Contract Research Organization (CRO) specializing in clinical research and bioanalytical services. Established in 2011 and headquartered in Guangzhou, the company provides a comprehensive range of services including bioequivalence (BE) studies, Phase I-IV clinical trials, and regulatory submission support. The firm is particularly noted for its expertise in bioanalysis, utilizing advanced LC-MS/MS platforms to support pharmacokinetic and pharmacodynamic evaluations. Beisheng Pharma operates in strict accordance with international GXP standards, serving both domestic Chinese pharmaceutical firms and international clients looking to enter the Chinese market. Their service portfolio also encompasses data management, biostatistics, and medical writing, making them a full-service partner for drug development.